Fibroids in Women of Reproductive Age and Women Pregnancy
NCT ID: NCT02620345
Last Updated: 2015-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
22 participants
INTERVENTIONAL
2010-01-31
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinically has shown that:
Uterine fibroids are associated with an Heavy or prolonged menstrual periods. Abnormal bleeding between menstrual periods.
Uterine fibroids are associated with an increased rate of spontaneous miscarriage, preterm labor, placenta abruption, malpresentation, labor dystocia, cesarean delivery, and postpartum hemorrhage, pain is the most common complication of fibroids during pregnancy. Can usually be controlled by conservative treatment on Dydrogesterone Multivitamin nature.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dydrogesterone M/ Women Pregnancy
* Reducing the size of fibroids with medication
* Drug: Dydrogesterone M 15mg/Fibroids/Women Pregnancy
* Dosage:
* 1tablet/24 hours/day/ (when seeing fibroids to 4 weeks after postpartum). Dydrogesterone 15mg/day Beta Carotene 4000 IU/day Ascorbic Acid 100 mg/day Cholecalciferol 400 IU/day Dl-Alpha Tocopheryl Acetate 11IU Thiamin Mononitrate 1.5 mg/day Riboflavin 1.7 mg/day Niacinamide 18 mg/day Pyridoxine Hydrochloride 2.6 mg/day Folic Acid 400 mcg/day Cyanocobalamin 4mcg/day Calcium Carbonate 150 mg/day Ferrous Fumarate 27 mg/day Zinc Oxide 25 mg/day
* The lost in size of fibroids throughout pregnancy after 48 weeks.
Dydrogesterone M ( case 1 )
Dydrogesterone Multivitamin nature
* Fibroids / Women Pregnancy ( discovered fibroids during pregnancy ) Dydrogesterone Multivitamin nature.
* 1tablet/24 hours/day (to 4 weeks after postpartum)
Dydrogesterone M/ Reproductive Age
* Reducing the size of fibroids with medication
* Drug: Dydrogesterone M 15mg/Fibroids/Reproductive Age
* Dosage:
* 1tablet/24 hours/day/24 weeks ( from discovered fibroids through 24 weeks). Dydrogesterone 15mg/day Beta Carotene 4000 IU/day Ascorbic Acid 100 mg/day Cholecalciferol 400 IU/day Dl-Alpha Tocopheryl Acetate 11IU Thiamin Mononitrate 1.5 mg/day Riboflavin 1.7 mg/day Niacinamide 18 mg/day Pyridoxine Hydrochloride 2.6 mg/day Folic Acid 400 mcg/day Cyanocobalamin 4mcg/day Calcium Carbonate 150 mg/day Ferrous Fumarate 27 mg/day Zinc Oxide 25 mg/day
* The lost in size of fibroids after 24 weeks.
Dydrogesterone M ( case 2 )
Dydrogesterone Multivitamin nature
* Fibroids/ Women of Reproductive age ( discovered fibroids )
* 1tablet/24 hours/day ( from discovered fibroids through 6 months)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dydrogesterone M ( case 1 )
Dydrogesterone Multivitamin nature
* Fibroids / Women Pregnancy ( discovered fibroids during pregnancy ) Dydrogesterone Multivitamin nature.
* 1tablet/24 hours/day (to 4 weeks after postpartum)
Dydrogesterone M ( case 2 )
Dydrogesterone Multivitamin nature
* Fibroids/ Women of Reproductive age ( discovered fibroids )
* 1tablet/24 hours/day ( from discovered fibroids through 6 months)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* If you might want to become pregnant in the future
* The size of the fibroids
* The location of the fibroids
* Your age and you might be
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Trieu, Nguyen Thi, M.D.
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Triệu, Nguyễn Thị, M.D.
Clinical Study
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nguyen Thi Trieu, Master
Role: STUDY_DIRECTOR
Tran Minh Duc, Dr.
Related Links
Access external resources that provide additional context or updates about the study.
Contemporary Management of Fibroids in Pregnancy
What is the treatment for uterine fibroids?
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dydrogesterone Multivitamin
Identifier Type: -
Identifier Source: org_study_id